Hepatic MiR-291b-3p Mediated Glucose Metabolism by Directly Targeting p65 to Upregulate PTEN Expression. - Wikidata - awgldk - TriplyDB

Hepatic MiR-291b-3p Mediated Glucose Metabolism by Directly Targeting p65 to Upregulate PTEN Expression.

Hepatic MiR-291b-3p Mediated Glucose Metabolism by Directly Targeting p65 to Upregulate PTEN Expression.

http://www.wikidata.org/entity/Q37559230

about

Hyaluronic acid 35 normalizes TLR4 signaling in Kupffer cells from ethanol-fed rats via regulation of microRNA291b and its target Tollip.miR-291b-3p mediated ROS-induced endothelial cell dysfunction by targeting HUR

P2860

Q47118108-BD809D7D-0F11-4474-882A-23DB3786105C Q58788617-67E17017-ED3A-4992-A48C-EF2EEB2DBFF9

P2860

Hepatic MiR-291b-3p Mediated Glucose Metabolism by Directly Targeting p65 to Upregulate PTEN Expression.

http://www.wikidata.org/entity/Q37559230

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 05 January 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Hepatic MiR-291b-3p Mediated G ...... to Upregulate PTEN Expression.

@en

Hepatic MiR-291b-3p Mediated G ...... to Upregulate PTEN Expression.

@nl

type

label

Hepatic MiR-291b-3p Mediated G ...... to Upregulate PTEN Expression.

@en

Hepatic MiR-291b-3p Mediated G ...... to Upregulate PTEN Expression.

@nl

prefLabel

Hepatic MiR-291b-3p Mediated G ...... to Upregulate PTEN Expression.

@en

Hepatic MiR-291b-3p Mediated G ...... to Upregulate PTEN Expression.

@nl

P1433

Q37559230-B945FF93-82BB-405D-8EDC-BA008465C326

P1476

Q37559230-9A671377-D4D4-4060-A00E-F76ECB7DD061

P2093

Q37559230-267AE26C-8D06-40CA-9520-0E9F002DE2B6

Q37559230-38D16A18-6456-4AAE-BE1D-37143581F866

Q37559230-3D17C842-9DF8-42F3-8981-07C2992123EA

Q37559230-4EF3B0DB-6866-43B8-A841-F07E33C149BF

Q37559230-52023ADC-5150-4741-AD88-BBB57E5464CE

Q37559230-559F7205-E2AF-4149-AA41-E356C85BC08E

Q37559230-5C393C0B-AE0C-4BA0-B8F9-6BDFC265502D

Q37559230-6B98DC6B-8111-4163-AD3E-E3286B9176B4

Q37559230-7DC690EF-B1FA-453E-8F97-1A8721D2E03E

Q37559230-A5325D88-8574-4061-8A22-C1E43AA293C9

P2860

Q37559230-01489551-D5EC-4F20-BFA5-94DF788E4D7D

Q37559230-021AA25C-8838-4434-88DC-31D4A359100E

Q37559230-0293C3AE-5295-49BB-9A08-0147CF380A79

Q37559230-10F69DEF-5087-42E5-A7CA-910B7DBA03C1

Q37559230-26C6AFA5-4BE6-425B-873B-48A9D58CB4A3

Q37559230-2E969304-EF22-40A0-8130-41C7E46BDD7F

Q37559230-33293568-FBBB-4CEE-93D7-48E01BAD5B5F

Q37559230-355DB55D-5DC1-47B3-BFC5-3B2A4F33E1F4

Q37559230-3978E90A-C283-4994-AE35-E0D443D31F22

Q37559230-43FF34BC-D3CF-4A64-9775-8A4265E1C43F

P2888

Q37559230-1E3B7AB1-2248-4032-B644-77461FAB2540

P304

Q37559230-EF862E80-D6C3-4DE4-BCAD-EE27B6DA2F4E

P31

Q37559230-36C391EB-BF32-49F6-B46D-551BB87F56F2

P356

Q37559230-9C664D54-48FB-45C1-9A32-D5FFC30E1ECA

P407

Q37559230-C470261C-0DB7-4EC3-965A-653219D38C5F

P478

Q37559230-9D8F8D63-8DFB-4CB6-AEA3-185EF2649C8F

P577

Q37559230-A61B22B6-B0F6-4E12-9835-DB1B99EDC769

P698

Q37559230-58AD14F9-5F03-4323-8F8F-39DAC6C06897

P921

Q37559230-6222bafb-293c-4a67-82ac-f0572cb9e616

P932

Q37559230-741E5537-8737-4CA4-8BE4-40C77A4883F3

P356

P1433

Scientific Reports

P1476

Hepatic MiR-291b-3p Mediated G ...... to Upregulate PTEN Expression.

@en

P2093

Chunxiao Yang

http://www.w3.org/2001/XMLSchema#string

Jian Li

http://www.w3.org/2001/XMLSchema#string

Jichun Yang

http://www.w3.org/2001/XMLSchema#string

Jun Guo

http://www.w3.org/2001/XMLSchema#string

Lin Dou

http://www.w3.org/2001/XMLSchema#string

Weili Yang

http://www.w3.org/2001/XMLSchema#string

Weiqing Tang

http://www.w3.org/2001/XMLSchema#string

Weiwei Fang

http://www.w3.org/2001/XMLSchema#string

Xiangyu Meng

http://www.w3.org/2001/XMLSchema#string

Xiuqing Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Most mammalian mRNAs are conserved targets of microRNAs

Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus

Influence of miRNA in insulin signaling pathway and insulin resistance: micro-molecules with a major role in type-2 diabetes

Insulin resistance as a physiological defense against metabolic stress: implications for the management of subsets of type 2 diabetes

RAS/ERK modulates TGFbeta-regulated PTEN expression in human pancreatic adenocarcinoma cells

Increased plasma levels of FABP4 and PTEN is associated with more severe insulin resistance in women with gestational diabetes mellitus.

Suppression of PTEN expression by NF-kappa B prevents apoptosis.

Interferon gamma-induced protein 10 is associated with insulin resistance and incident diabetes in patients with nonalcoholic fatty liver disease.

Apolipoprotein CIII links islet insulin resistance to β-cell failure in diabetes.

MiR-19a regulates PTEN expression to mediate glycogen synthesis in hepatocytes.

P2888

P304

39899

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP39899

http://www.w3.org/2001/XMLSchema#string

P407

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28054586

http://www.w3.org/2001/XMLSchema#string

P921

P932

5214750

http://www.w3.org/2001/XMLSchema#string